Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03936660 · ClinicalTrials.gov registry record · NA
A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease
A NA study of Diabetes Mellitus, Type 2 and Cardiovascular Diseases, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 1,049
- Enrollment target
- 20
- Study locations
NCT03936660: Completed NA study of Diabetes Mellitus, Type 2 and Cardiovascular Diseases, sponsored by Duke University.
NCT03936660 is a NA study of Diabetes Mellitus, Type 2 and Cardiovascular Diseases that has completed, run by Duke University. The registered enrollment target is 1,049 participants, below the 4,482-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (77% lower). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03936660, a NA study of Diabetes Mellitus, Type 2 and Cardiovascular Diseases, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,049 participants
- Enrollment target
- 20
- Study locations
Study Summary
COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention to improve the management of patients with type 2 diabetes mellitus and cardiovascular disease.
Primary Outcome
Proportion of patients prescribed all three groups of guideline-recommended therapies for management for T2DM and CVD at last follow-up visit. Groups were defined as (1) high-intensity statins (40-80 mg/d atorvastatin or 20-40 mg/d rosuvastatin); (2) ACEIs or ARBs including angiotensin receptor-neprilysin inhibitors (ARNIs); and (3) SGLT2 inhibitors and/or GLP-1RAs with proven cardiovascular benefit (SGLT2 inhibitors: empagliflozin, dapagliflozin, or canagliflozin; GLP-1RAs: liraglutide, semaglu
Conditions Studied
Interventions
- OTHER Intense Education Intervention
Study Locations (20)
Florida
- Orlando Heart and Vascular Institute - Altamonte Springs
- Riverside Medical Center/Synergy Healthcare - Bradenton
- Lennar Foundation/Univ. of Miami - Coral Gables
- Citrus Cardiology - Inverness
- Baptist Health Research Institute - Jacksonville
- Advanced Research for Health Improvement, LLC - Naples
- Cardiovascular Inst. of Northwest Florida - Panama City
- Bayfront Cardiovascular Associates - St. Petersburg
- Interventional Cardiac Consultants - Trinity
Alabama
- Grandview Health/Alabama Cardiovascular Group - Birmingham
- USA Cardiology - Mobile
California
- Stanford University - Stanford
- Blue Coast Cardiology - Vista
Illinois
- Advocate Heart Institute - Chicago
- Advanced Heart Care Group/Medicoricium LLC - Fairview Heights
Alaska
- Alaska Heart and Vascular Institute - Anchorage
Arizona
- Dignity Health/DHMG Specialty Medicine - Phoenix
Colorado
- Aurora Denver Cardiology - Denver
Connecticut
- Bridgeport Hospital - Bridgeport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,049 participants |
| Start Date | 2019-07-25 |
| Est. Completion | 2022-12-30 |
| Phase | NA |
What the finished NCT03936660 record still lists
NCT03936660 is an interventional study that assigns participants to a tested intervention. Its 1,049 participants enrollment target places it among the larger protocols in the corpus, below the 4,482-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (77% lower).
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Intense Education Intervention is the first listed.
NCT03936660 names 20 study sites across 9 states, led by Florida, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT03936660 about?
NCT03936660 is a clinical study titled "A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease". COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention to improve the management of patients with type 2 diabetes mellitus and cardiovascular disease.
What is the current status of trial NCT03936660?
This trial is currently completed. It is a NA study. The enrollment target is 1,049 participants. The study started on 2019-07-25. Estimated completion is 2022-12-30.
What conditions does trial NCT03936660 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Cardiovascular Diseases.
What interventions are being tested in trial NCT03936660?
The interventions under investigation include: Intense Education Intervention (OTHER).
Who is sponsoring clinical trial NCT03936660?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03936660 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03936660's enrollment target sits among peer trials
1,049 31st of 348 higher than 317 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI